Cutaneous reaction associated with weekly docetaxel administration

Journal of Oncology Pharmacy Practice

Volumn 15, Issue 1, 2009, Pages 29-34

  Chew, Lita ^a   Chuen, Vivianne Shih Lee ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Cutaneous reaction; Docetaxel; Skin toxicity

Indexed keywords

BETAMETHASONE DIPROPIONATE; CAPECITABINE; CARBOPLATIN; CISPLATIN; CLOBETASOL PROPIONATE; CLOTRIMAZOLE; CLOXACILLIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; GENTAMICIN; HEPARINOID; HYDROCORTISONE; PACLITAXEL; PAMIDRONIC ACID; PEMETREXED; PSEUDOMONIC ACID; TAMOXIFEN;

ADULT; ARTICLE; BLISTER; BONE METASTASIS; BREAST CANCER; CLINICAL ARTICLE; COLON CANCER; CONTINUOUS INFUSION; CRYOTHERAPY; DRY SKIN; ERYTHEMA; FEMALE; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; LIVER METASTASIS; LUNG METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CANCER; PERITONEUM METASTASIS; PRIORITY JOURNAL; PRURITUS; SKIN EXFOLIATION; SKIN MANIFESTATION; SKIN PAIN;

ADULT; ANTINEOPLASTIC AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG ERUPTIONS; FEMALE; HUMANS; HYPERPIGMENTATION; HYPOPIGMENTATION; MALE; MIDDLE AGED; NEOPLASMS; TAXOIDS; TIME FACTORS;

EID: 61749096350     PISSN: 10781552     EISSN: None     Source Type: Journal    
DOI: 10.1177/1078155208096111     Document Type: Article

References (21)

1. Sanofi Aventis US website. Taxotere homepage. Available at: http://www.taxotere.com/hcp_default.aspx. Accessed January 18 2008.
2. National Cancer Institute US website. Drug Information: Taxotere®. Available at: http://www.cancer.gov/cancertopics/druginfo/docetaxel. Accessed January 18 2008.
3. Zimmerman GC, Keeling JH, Burris HA et al. Acute cutaneous reactions to docetaxel, a new chemotherapeutic agent. Arch Dermatol 1995; 131(2): 202-6.
4. Ford HE, Yap YS, Miles DW et al. A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer. Cancer Chemother Pharmacol 2006; 58(6): 809-15.
5. Battafarano DF, Zimmerman GC, Older SA, Keeling JH, Burris HA Docetaxel (Taxotere) associated scleroderma-like changes of the lower extremities. A report of three cases. Cancer 1995; 76(1): 110-15.
6. Correia O., Azevedo C., Pinto Ferreira E., Braga Cruz F., Polonia J. Nail changes secondary to docetaxel (Taxotere). Dermatology 1999; 198(3): 288-90.
7. Flory SM, Solimando Jr, DA, Webster GF, Dunton CJ, Neufeld JM, Haffey MB Onycholysis associated with weekly administration of paclitaxel. Ann Pharmacother 1999; 33(5): 584-86.
8. Cleveland MG, Ajaikumar BS, Reganti R. Cutaneous fibrosis induced by docetaxel: A case report. Cancer 2000; 88(5): 1078-81.
9. Chu CY, Yang CH, Yang CY, Hsiao GH, Chiu HC Fixed erythrodysaesthesia plaque due to intravenous injection of docetaxel. Br J Dermatol 2000; 142(4): 808-11.
10. Schrijvers D., Van Den Brande J., Vermorken JB Supravenous discoloration of the skin due to docetaxel treatment. Br J Dermatol 2000; 142(5): 1069-70.
11. Hassett G., Harnett P., Manolios N. Scleroderma in association with the use of docetaxel (taxotere) for breast cancer. Clin Exp Rheumatol 2001; 19(2): 197-200.
12. Hirai K., Ishiko O., Nakajima S. et al. Local erythematous dermatitis after intravenous docetaxel. Gynecol Obstet Invest 2002; 53(2): 118-20.
13. Piroth MD, Krempien R., Wannenmacher M., Zierhut D. Radiation recall dermatitis from docetaxel. Onkologie 2002; 25(5): 438-40.
14. Moisidis C., Mobus V. Erythema multiforme major following docetaxel. Arch Gynecol Obstet 2005; 271(3): 267-69.
15. Tallon B., Lamb S. Flagellate erythema induced by docetaxel. Clin Exp Dermatol 2008; 33(3): 276-77.
16. Poikonen P., Sjostrom J., Klaar S. et al. Skin toxicity as a risk factor for major infections in breast cancer patients treated with docetaxel. Acta Oncol 2004; 43(2): 190-95.
17. Raley J., Geisler JP, Buekers TE, Sorosky JI Docetaxel extravasation causing significant delayed tissue injury. Gynecologic Oncology 2000; 78(2): 259-60.
18. Berghammer P., Pohnl R., Baur M., Dittrich C. Docetaxel extravasation. Support Care Cancer 2001; 9(2): 131-34.
19. Ho CH, Yang CH, Chu CY Vesicant-type reaction due to docetaxel extravasation. Acta Dermato-Venereologica 2003; 83(6): 467-68.
20. El Saghir NS, Otrock ZK Docetaxel extravasation into the normal breast during breast cancer treatment. AntiCancer Drugs 2004; 15(4): 401-04.
21. Barcelo R., Viteri A., Munoz A., Carrera S., Rubio I., Lopez-Vivanco G. Extravasation of docetaxel: A red hand syndrome. Archives of Dermatology 2005; 141(10): 1326-27.